The new antidepressants
نویسندگان
چکیده
منابع مشابه
Development of new antidepressants
The development of the first effective antidepressants in the late 1950s marked a turning point in the treatment of depressive illness. In 1957 the monoamine oxidase inhibitor (MAOI) iproniazid was discovered by chance, while searching for new antituberculous drugs. One year later the tricyclic antidepressant (TCA) imipramine was introduced, having been developed originally as an antipsychotic....
متن کاملNew antidepressants in pregnancy.
QUESTION I have read that fluoxetine is the drug of choice for treating depression during pregnancy. One of my patients, who did not respond to the "old" selective serotonin reuptake inhibitors, is doing well on venlafaxine and is now 6 weeks pregnant. What advice should I give her? ANSWER Fluoxetine is recommended because to date it has the most evidence of its safety. It is important that w...
متن کاملNew antidepressants or more of the same?
New antidepressants or more of the same? Effective antidepressant drugs have been available for half a century since the fi rst monoamine oxidase inhibitor (MAOI), isoniazid, and the prototype tricyclic antidepres-sant (TCA), imipramine, were introduced into therapy (Leonard and Spencer 1990). The use of MAOIs declined when reports appeared of hypertensive crises associated with ingestion of di...
متن کاملSerotonergic mechanisms and the new antidepressants
The renaissance in serotonin pharmacology of the past decade is resulting in the discovery of a vast array of new medications now undergoing human testing and which are expected to burst forth into psychiatry over the next decade. This proliferation of new drug therapies is the result of advances in the basic neuroscience of serotonin being translated into clinical applications. The challenge n...
متن کاملSerotonergic mechanisms and the new antidepressants.
The renaissance in serotonin pharmacology of the past decade is resulting in the discovery of a vast array of new medications now undergoing human testing and which are expected to burst forth into psychiatry over the next decade. This proliferation of new drug therapies is the result of advances in the basic neuroscience of serotonin being translated into clinical applications. The challenge n...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Australian Prescriber
سال: 1995
ISSN: 0312-8008,1839-3942
DOI: 10.18773/austprescr.1995.084